Clinical Trials Browser

Phase 2 × INDUSTRY × guadecitabine × Clear all

NCT01696032 2024-08-27

SGI-110

Phase 2 Completed

120 enrolled 22 charts

Ovarian Neoplasms

NCT01752933 2024-08-27

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Completed

52 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03603964 2024-08-27

Guadecitabine Extension Study

Phase 2 Terminated

35 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute